Financial Network Wealth Advisors LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 2012031
MURRAY, UT
Position in LGND
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$6,321
+$3,526 QoQ
Shares Held
20
+42.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#372
of 406 holders
Holding Since
Jun 2024
8 quarters on record
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Financial Network Wealth Advisors LLC holds $234,517 across 15 Biotechnology names. LGND ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
182 | $90,404 | |
| 2 | TECH |
BIO-TECHNE Corp
|
607 | $42,884 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
66 | $41,153 | |
| 4 | OCUL |
Ocular Therapeutix, Inc
|
2,638 | $25,905 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
200 | $6,864 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
This page
|
20 | $6,321 | |
| 7 | MRNA |
Moderna, Inc.
|
86 | $6,022 | |
| 8 | IMNM |
Immunome Inc.
|
179 | $3,793 |
All Filings in LGND
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,321 | 20 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,795 | 14 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,646 | 14 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,251 | 24 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $2,728 | 24 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,628 | 25 | Shares | Sole | 2025-05-13 | |
| 2024-09-30 | $2,502 | 25 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,769 | 21 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||